CTMX - Cytomx Therapeutics, Inc.

CTMX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	McCarthy Sean A.	1.08M	$6.93M	-
VP	Belvin Marcia	300.8K	$1.93M	-
CFO	Ogden Christopher	295.3K	$900.7K	-
Other	Chu Yu-Waye	189.4K	$1.22M	-
Other	Carvajal Alejandra	100.0K	-	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 18, 2025	McCarthy Sean A.67	CEO	Sell	37,656	$0.60	$22,555.94	-3.6%	+307.5%	+628.8%
Mar 18, 2025	Ogden Christopher50	Chief Financial Officer	Sell	8,551	$0.60	$5,122.05	-4.1%	+307.5%	+628.8%
Mar 18, 2025	Chu Yu-Waye72	Chief Medical Officer	Sell	4,025	$0.60	$2,410.98	-2.9%	+307.5%	+628.8%
Mar 18, 2025	Rowland Lloyd A50	General Counsel	Sell	10,203	$0.60	$6,111.60	-7.8%	+307.5%	+628.8%
Mar 18, 2025	Belvin Marcia49	SVP, Chief Scientific Officer	Sell	19,512	$0.60	$11,687.69	-7.3%	+307.5%	+628.8%
Aug 20, 2024	Rowland Lloyd A50	General Counsel	Sale+OE	4,181	$1.23	$5,138.87	-3.1%	-30.4%	+58.9%
Aug 20, 2024	Ogden Christopher50	Chief Financial Officer	Sale+OE	1,984	$1.23	$2,438.53	-1.8%	-30.4%	+58.9%
Aug 20, 2024	McCarthy Sean A.67	CEO	Sale+OE	13,898	$1.23	$17,082.03	-2.1%	-30.4%	+58.9%
Aug 20, 2024	Landau Jeffrey B55	Chief Business Officer	Sale+OE	4,181	$1.23	$5,138.87	-3.4%	-30.4%	+58.9%
Aug 20, 2024	Belvin Marcia49	SVP, Chief Scientific Officer	Sale+OE	4,181	$1.23	$5,138.87	-2.3%	-30.4%	+58.9%